首页 正文

Targeting cancer-cell mitochondria using Tigecycline improves radiotherapy response in colorectal cancer cell line

{{output}}
Background: Colorectal cancer (CRC) is the third most common cancer worldwide and causes more than 50,000 deaths in the United States each year. Due to the limited therapeutic options and poor prognosis in CRC, extensive research... ...